Literature DB >> 34185937

Symptoms and functioning improve after chronic hepatitis C cure as assessed by the Memorial Symptom Assessment Scale and PROMIS measures.

Hannah P Kim1, Angela Edwards2, Bryce B Reeve3, Carol E Golin4, Donna M Evon1.   

Abstract

Entities:  

Keywords:  antiviral agents; fatigue; health-related quality of life; hepatitis C virus; pain

Mesh：

Year:  2021        PMID： 34185937      PMCID： PMC8458231          DOI： 10.1111/jvh.13561

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN： 1352-0504            Impact factor:   3.517


× No keyword cloud information.
  8 in total

1.  Improving hepatitis C direct-acting antiviral access and uptake: A role for patient-reported outcomes and lived experience.

Authors:  Stelliana Goutzamanis; Joseph Doyle; Peter Higgs; Margaret Hellard
Journal:  J Viral Hepat       Date:  2018-11-06       Impact factor: 3.728

2.  Responsiveness to Change and Minimally Important Differences of the Patient-Reported Outcomes Measurement Information System Gastrointestinal Symptoms Scales.

Authors:  Dinesh Khanna; Ron D Hays; Andrew B Shreiner; Gil Y Melmed; Lin Chang; Puja P Khanna; Roger Bolus; Cynthia Whitman; Sylvia H Paz; Tonya Hays; Steven P Reise; Brennan Spiegel
Journal:  Dig Dis Sci       Date:  2017-03-01       Impact factor: 3.199

3.  Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy.

Authors:  D M Evon; J Amador; P Stewart; B B Reeve; A S Lok; R K Sterling; A M Di Bisceglie; N Reau; M Serper; S Sarkar; J K Lim; C E Golin; M W Fried
Journal:  Aliment Pharmacol Ther       Date:  2018-01-29       Impact factor: 8.171

4.  The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress.

Authors:  R K Portenoy; H T Thaler; A B Kornblith; J M Lepore; H Friedlander-Klar; E Kiyasu; K Sobel; N Coyle; N Kemeny; L Norton
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

5.  "They treated me like a leper". Stigmatization and the quality of life of patients with hepatitis C.

Authors:  Susan Zickmund; Evelyn Y Ho; Masahiro Masuda; Laura Ippolito; Douglas R LaBrecque
Journal:  J Gen Intern Med       Date:  2003-10       Impact factor: 5.128

6.  "If I Get Cured, My Whole Quality of Life Will Change": Patients' Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis C.

Authors:  Donna M Evon; Hannah P Kim; Angela Edwards; Jessica Carda-Auten; Bryce B Reeve; Carol E Golin; Michael W Fried
Journal:  Dig Dis Sci       Date:  2021-02-02       Impact factor: 3.199

Review 7.  Review of patient-reported outcome measures in chronic hepatitis C.

Authors:  Leah Kleinman; Sally Mannix; Yong Yuan; Shannon Kummer; Gilbert L'Italien; Dennis Revicki
Journal:  Health Qual Life Outcomes       Date:  2012-08-07       Impact factor: 3.186

8.  Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study.

Authors:  Donna M Evon; Souvik Sarkar; Jipcy Amador; Anna S Lok; Richard K Sterling; Paul W Stewart; Bryce B Reeve; Marina Serper; Nancy Reau; K Rajender Reddy; Adrian M Di Bisceglie; David R Nelson; Carol E Golin; Joseph K Lim; Michael W Fried
Journal:  J Hepatol       Date:  2019-05-13       Impact factor: 30.083
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.